Pentadecapeptide BPC 157 shortens duration of tetracaine- and oxybuprocaine-induced corneal anesthesia in rats
however, any prior adverse reaction to niacinamide/NAD+ products would warrant against use of NAD+ Injection
Risk assessment for the amino acids taurine, L-glutamine and L-arginine
This guide covers the complete BPC-157 dosing picture: mechanism of action, reconstitution and concentration math, a quick-reference dosing table, goal-specific protocols by condition and body weight, arginate versus acetate salt forms, evidence strength per claim, side effects and who should avoid it, common dosing mistakes, sourcing verification, WADA and regulatory status, and stack options
Nature 479 , 117121 (2011)
Once a week